Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 25,096 | 28,584 | 31,693 | 26,896 | 27,068 |
| Operating Income | -25,096 | -28,584 | -31,693 | -26,896 | -27,068 |
| Other Income | 4,948 | 3,249 | 3,149 | 3,716 | 3,912 |
| Pre-tax Income | -20,148 | -25,335 | -28,544 | -23,180 | -23,156 |
| Net Income Continuous | -20,148 | -25,335 | -28,544 | -23,180 | -23,156 |
| Net Income | $-20,148 | $-25,335 | $-28,544 | $-23,180 | $-23,156 |
| EPS Basic Total Ops | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 |
| EPS Basic Continuous Ops | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 |
| EPS Diluted Total Ops | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 |
| EPS Diluted Continuous Ops | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.49 | -0.57 | -0.46 | -0.48 |
| EBITDA(a) | $-25,344 | $-28,430 | $-31,664 | $-25,840 | $-26,276 |